These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 25663986)

  • 1. Repetitive transcranial magnetic stimulation (rTMS) augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant obsessive-compulsive disorder (OCD): a meta-analysis of randomized controlled trials.
    Ma ZR; Shi LJ
    Int J Clin Exp Med; 2014; 7(12):4897-905. PubMed ID: 25663986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repetitive transcranial magnetic stimulation (rTMS) for obsessive-compulsive disorder (OCD): an exploratory meta-analysis of randomized and sham-controlled trials.
    Berlim MT; Neufeld NH; Van den Eynde F
    J Psychiatr Res; 2013 Aug; 47(8):999-1006. PubMed ID: 23615189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repetitive transcranial magnetic stimulation (r-TMS) and selective serotonin reuptake inhibitor-resistance in obsessive-compulsive disorder: A meta-analysis and clinical implications.
    Pellegrini L; Garg K; Enara A; Gottlieb DS; Wellsted D; Albert U; Laws KR; Fineberg NA
    Compr Psychiatry; 2022 Oct; 118():152339. PubMed ID: 35917621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Meta-Analysis of the Effectiveness of Different Cortical Targets Used in Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Obsessive-Compulsive Disorder (OCD).
    Rehn S; Eslick GD; Brakoulias V
    Psychiatr Q; 2018 Sep; 89(3):645-665. PubMed ID: 29423665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis.
    Issari Y; Jakubovski E; Bartley CA; Pittenger C; Bloch MH
    J Clin Psychiatry; 2016 May; 77(5):e605-11. PubMed ID: 27249090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Better than treated as usual: Transcranial magnetic stimulation augmentation in selective serotonin reuptake inhibitor-refractory obsessive-compulsive disorder, mini-review and pilot open-label trial.
    Pallanti S; Marras A; Salerno L; Makris N; Hollander E
    J Psychopharmacol; 2016 Jun; 30(6):568-78. PubMed ID: 26843373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD).
    Soomro GM; Altman D; Rajagopal S; Oakley-Browne M
    Cochrane Database Syst Rev; 2008 Jan; 2008(1):CD001765. PubMed ID: 18253995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of 5-hydroxytryptamine-3 (5-HT3) receptor antagonists in augmentation with selective serotonin reuptake inhibitors (SSRIs) in the treatment of moderate to severe obsessive-compulsive disorder: a systematic review and meta-analysis of randomized clinical trials.
    Eissazade N; Mosavari H; Eghdami S; Boroon M; Ashrafi F; Shalbafan M
    Sci Rep; 2023 Nov; 13(1):20837. PubMed ID: 38012263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder.
    Varigonda AL; Jakubovski E; Bloch MH
    J Am Acad Child Adolesc Psychiatry; 2016 Oct; 55(10):851-859.e2. PubMed ID: 27663940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of serotonin transporter gene on rTMS augmentation of SSRIs for obsessive compulsive disorder.
    Zhang K; Fan X; Yuan J; Yin J; Su H; Hashimoto K; Wang G
    Neuropsychiatr Dis Treat; 2019; 15():1771-1779. PubMed ID: 31308670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Meta-analysis of Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder.
    Steuber ER; McGuire JF
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2023 Nov; 8(11):1145-1155. PubMed ID: 37343662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of repetitive transcranial magnetic stimulation protocols for obsessive-compulsive disorder: A network meta-analysis.
    Vinod P; Thatikonda NS; Malo PK; Bhaskarapillai B; Arumugham SS; Janardhan Reddy YC
    Asian J Psychiatr; 2024 Apr; 94():103962. PubMed ID: 38377642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and clinical predictors of response to rTMS treatment in pharmacoresistant obsessive-compulsive disorder (OCD): a retrospective study.
    Rostami R; Kazemi R; Jabbari A; Madani AS; Rostami H; Taherpour MA; Molavi P; Jaafari N; Kuo MF; Vicario CM; Nitsche MA; Salehinejad MA
    BMC Psychiatry; 2020 Jul; 20(1):372. PubMed ID: 32677923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repetitive Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: A Meta-analysis of Randomized, Sham-Controlled Trials.
    Perera MPN; Mallawaarachchi S; Miljevic A; Bailey NW; Herring SE; Fitzgerald PB
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Oct; 6(10):947-960. PubMed ID: 33775927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A benzisothiazole derivative and antipsychotic agent, perospirone, for augmentation of selective serotonin reuptake inhibitors (SSRIs) in refractory obsessive-compulsive disorder (OCD): two patient case series.
    Matsunaga H; Matsui T; Ohya K; Okino K; Hayashida K; Maebayashi K; Kiriike N; Stein DJ
    Int J Psychiatry Clin Pract; 2006; 10(2):142-5. PubMed ID: 24940965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of pre-supplementary motor area transcranial direct current stimulation for treatment resistant obsessive compulsive disorder: A randomized, double blinded, sham controlled trial.
    Gowda SM; Narayanaswamy JC; Hazari N; Bose A; Chhabra H; Balachander S; Bhaskarapillai B; Shivakumar V; Venkatasubramanian G; Reddy YCJ
    Brain Stimul; 2019; 12(4):922-929. PubMed ID: 30808612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant Priming Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Obsessive-Compulsive Disorder: In Search of a New Paradigm!
    Vidya KL; Rao PG; Goyal N
    J ECT; 2022 Mar; 38(1):e1-e8. PubMed ID: 34519685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of early augmentation with repetitive transcranial magnetic stimulation in the treatment of drug-free patients with obsessive-compulsive disorder.
    Joshi M; Kar SK; Dalal PK
    CNS Spectr; 2022 Jan; ():1-7. PubMed ID: 35082003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repetitive transcranial magnetic stimulation of the supplementary motor area in treatment-resistant obsessive-compulsive disorder: An open-label pilot study.
    Lee YJ; Koo BH; Seo WS; Kim HG; Kim JY; Cheon EJ
    J Clin Neurosci; 2017 Oct; 44():264-268. PubMed ID: 28687447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Non-Invasive Brain Stimulation for Refractory Obsessive-Compulsive Disorder: A Meta-Analysis of Randomized Controlled Trials.
    Zhou S; Fang Y
    Brain Sci; 2022 Jul; 12(7):. PubMed ID: 35884749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.